Core Insights - MetLife reported revenue of 17.61billionforthequarterendedSeptember2024,adecreaseof3.41.93, down from 1.97inthesamequarterlastyear[1]−TherevenuefellshortoftheZacksConsensusEstimateof18.47 billion by 4.66%, and the EPS was 10.65% below the consensus estimate of 2.16[1]FinancialPerformanceMetrics−TotalAdjustedRevenueforLatinAmericawas1.93 billion, slightly below the estimated 1.98billion,reflectingayear−over−yearincreaseof4.46 million, significantly lower than the estimated 16.67million,markingayear−over−yeardeclineof166.72.84 billion, below the estimated 3.02billion,withayear−over−yearincreaseof2.85.23 billion, exceeding the estimated 5.13billion,withayear−over−yearincreaseof6.91.23 billion, below the estimated 1.33billion,representingayear−over−yeardeclineof8673 million, below the estimated 688.58million,withayear−over−yeardecreaseof1.8981 million, below the estimated $1.01 billion, reflecting a year-over-year decline [3] Stock Performance - MetLife shares have returned +1.3% over the past month, compared to the Zacks S&P 500 composite's +1.8% change, with a current Zacks Rank of 3 (Hold) indicating potential performance in line with the broader market [3]